<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> is widely observed in clinical practice </plain></SENT>
<SENT sid="1" pm="."><plain>We have examined the effect of a single administration of the <z:chebi fb="0" ids="37733">cholinesterase inhibitor</z:chebi> <z:chebi fb="0" ids="42944">galanthamine</z:chebi> (2mg kg(-1) i.p.) 25 min after reperfusion in male Sprague-Dawley rats (180 +/- 20 g) after a 20-min common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Twenty-four-hours post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> there was no difference in motor co-ordination or muscle tonus of the rats treated with or without <z:chebi fb="0" ids="42944">galanthamine</z:chebi> as assessed by the rota-rod test </plain></SENT>
<SENT sid="3" pm="."><plain>Learning ability was examined using the shuttle-box test, evaluating the latency time and the number of errors for six days in succession </plain></SENT>
<SENT sid="4" pm="."><plain>The performance of the ischaemic saline-injected rats was significantly impaired on days 4, 5, 6 (latency time) compared with the non-ischaemic rats and with the ischaemic animals administered <z:chebi fb="0" ids="42944">galanthamine</z:chebi> (P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>Similar results were obtained when counting the number of errors (failure to cross the cage during conditioned or unconditioned stimulus) </plain></SENT>
<SENT sid="6" pm="."><plain>The monitoring of body temperature during the first 12-h post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> did not show any significant difference between the groups </plain></SENT>
<SENT sid="7" pm="."><plain>The data showed a beneficial effect of <z:chebi fb="0" ids="42944">galanthamine</z:chebi> on the recovery of learning ability when administered once only post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>This suggests a direct effect on the early pathologic mechanisms of <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> damage </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="37733">Cholinesterase inhibitors</z:chebi> may prove useful in the early clinical treatment of ischaemic conditions </plain></SENT>
</text></document>